News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
840,125 Results
Type
Article (86116)
Company Profile (655)
Press Release (753354)
Section
Business (232510)
Career Advice (4123)
Deals (39702)
Drug Delivery (127)
Drug Development (90874)
Employer Resources (195)
FDA (18049)
Job Trends (17304)
News (396090)
Policy (39676)
Tag
Academia (2982)
Alliances (56717)
Alzheimer's disease (1433)
Approvals (18001)
Artificial intelligence (252)
Bankruptcy (400)
Best Places to Work (12633)
Biotechnology (450)
Breast cancer (250)
Cancer (1911)
Cardiovascular disease (154)
Career advice (3524)
CAR-T (147)
Cell therapy (419)
Clinical research (72714)
Collaboration (752)
Compensation (392)
COVID-19 (2843)
C-suite (187)
Data (1733)
Diabetes (244)
Diagnostics (6843)
Earnings (95633)
Employer resources (166)
Events (128604)
Executive appointments (623)
FDA (19049)
Funding (670)
Gene therapy (297)
GLP-1 (788)
Government (5095)
Healthcare (20849)
Infectious disease (2974)
Inflammatory bowel disease (139)
Interviews (811)
IPO (17773)
Job creations (5183)
Job search strategy (2860)
Layoffs (524)
Legal (10089)
Lung cancer (280)
Manufacturing (276)
Medical device (14522)
Medtech (14527)
Mergers & acquisitions (22310)
Metabolic disorders (658)
Neuroscience (1907)
NextGen: Class of 2025 (7662)
Non-profit (5077)
Northern California (2239)
Obesity (363)
Opinion (264)
Patents (187)
People (64850)
Phase I (22428)
Phase II (31583)
Phase III (23784)
Pipeline (815)
Postmarket research (3552)
Preclinical (10056)
Radiopharmaceuticals (264)
Rare diseases (372)
Real estate (7382)
Regulatory (26466)
Research institute (2650)
Resumes & cover letters (649)
Southern California (1937)
Startups (4284)
United States (20558)
Vaccines (732)
Weight loss (275)
Date
Today (122)
Last 7 days (864)
Last 30 days (2958)
Last 365 days (37094)
2025 (5849)
2024 (37954)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1269)
Arizona (248)
Asia (49810)
Australia (8780)
California (5235)
Canada (1786)
China (439)
Colorado (240)
Connecticut (258)
Europe (114133)
Florida (755)
Georgia (183)
Illinois (546)
Indiana (294)
Maryland (827)
Massachusetts (4093)
Michigan (224)
Minnesota (373)
New Jersey (1482)
New York (1482)
North Carolina (1006)
Northern California (2239)
Ohio (187)
Pennsylvania (1164)
South America (1649)
Southern California (1937)
Texas (769)
Utah (162)
Washington State (519)
840,125 Results for "shangdong simcere medgenn bio pharmaceutical co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Business
Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
Connect Biopharma Holdings Limited announced that two of its wholly owned subsidiaries, Connect Biopharma Hong Kong Limited and Suzhou Connect Biopharma Co., Ltd., have entered into an exclusive license and collaboration agreement with Simcere Pharmaceutical Co., Ltd., a subsidiary of Simcere Pharmaceutical Group Ltd., to develop and commercialize Connect Biopharma’s rademikibart in Greater China.
November 21, 2023
·
6 min read
Press Releases
Fermion and Simcere Enter into an Exclusive License and Collaboration Agreement for China’s First SSTR4 Agonist Targeting Pain
January 19, 2025
·
3 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
Policy
Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA
On June 25, 2024, Simcere Zaiming, an innovative oncology company and a subsidiary of Simcere Pharmaceutical Group, announced that Enlituo®, a new generation anti-epidermal growth factor receptor antibody drug developed in collaboration with Mabpharm Limited, has recently received approval from the China National Medical Administration for marketing.
June 26, 2024
·
4 min read
Press Releases
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
November 11, 2024
·
4 min read
Press Releases
Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema
November 8, 2024
·
7 min read
Business
YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.
YS Biopharma Co., Ltd. today issues an official response to the notice of extraordinary meeting of shareholders of YS Biopharma Co., Ltd.
February 12, 2024
·
9 min read
Press Releases
CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference
February 10, 2025
·
2 min read
1 of 84,013
Next
